Paper Details
- Home
- Paper Details
Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer.
Author: AzzaroneBruno, AzziSandy, BaldacciGiuseppe, BaïlleDorothée, DingliFlorent, EidPierre, El BannaNadine, HatemElie, HeTiantian, Heneman-MasurelAmélie, HuangMeng-Er, LoewDamarys, MassonVanessa, VernisLaurence
Original Abstract of the Article :
Cancer cells from different origins exhibit various basal redox statuses and thus respond differently to intrinsic or extrinsic oxidative stress. These intricate characteristics condition the success of redox-based anticancer therapies that capitalize on the ability of reactive oxygen species to ach...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1093/jnci/djy149
データ提供：米国国立医学図書館（NLM）
Auranofin and Vitamin C: A Promising Combination for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), a particularly aggressive form of breast cancer, poses a significant challenge for oncologists. This research investigates the potential of a novel drug combination, auranofin and vitamin C, in targeting TNBC. The study delves into the intricate interplay between oxidative stress and cancer cell biology, exploring how this combination could exploit the unique metabolic characteristics of TNBC cells to achieve selective and effective cell killing.
A New Weapon Against TNBC
The study's findings suggest that the combination of auranofin and vitamin C could be a promising therapeutic approach for TNBC. This combination targets the unique redox status of TNBC cells, inducing oxidative stress and selectively killing cancer cells while minimizing damage to healthy cells. The study highlights the potential of this approach to overcome the limitations of current TNBC treatments, offering hope for more effective and targeted therapies.
A Journey Towards Personalized Cancer Treatment
The study's findings pave the way for more personalized cancer treatment approaches. The combination of auranofin and vitamin C demonstrates the potential of exploiting the specific metabolic vulnerabilities of TNBC cells to achieve targeted and effective therapy. This research encourages continued exploration of redox-based therapies for various cancer types, potentially leading to more effective and less toxic treatments.
Dr.Camel's Conclusion
Just as a camel can navigate the scorching desert heat by storing water in its hump, researchers are navigating the challenging landscape of TNBC, seeking to harness the power of oxidative stress to effectively target and destroy these aggressive cancer cells. This study offers a promising path towards new and effective treatment options for TNBC, potentially improving the lives of patients diagnosed with this devastating disease.
Date :
- Date Completed 2020-02-03
- Date Revised 2020-05-11
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.